David N Juurlink. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic useCardiovascular Diseases/epidemiologyChemistry, PharmaceuticalClopidogrelCoronary Artery Disease/drug therapyDrug InteractionsDrug Therapy, CombinationGastrointestinal Hemorrhage/prevention & controlHumansOmeprazole/therapeutic usePantoprazolePlatelet Aggregation Inhibitors/therapeutic useProton Pump Inhibitors/adverse effectsProton Pump Inhibitors/therapeutic useTiclopidine/adverse effectsTiclopidine/analogs & derivativesTiclopidine/therapeutic use
Substances: See more » 2-PyridinylmethylsulfinylbenzimidazolesPlatelet Aggregation InhibitorsProton Pump InhibitorsClopidogrelPantoprazoleOmeprazoleTiclopidine
Year: 2011 PMID: 21323548 DOI: 10.1056/NEJMc1013859
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245